Mitha, Essack
Krivan, Gergely
Jacobs, Frederique
Nagler, Arnon
Alrabaa, Sally
Mykietiuk, Analia
Kenwright, Andrew
Le Pogam, Sophie
Clinch, Barry
Vareikiene, Loreta
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients
https://doi.org/10.1007/s40121-019-00271-8
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd
Article History
Received: 14 August 2019
First Online: 30 October 2019